APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biologic Therapeutics Drugs Market Analysis and Forecast 2026-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchBiologic Therapeutics Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutics Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutics Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutics Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Biologic Therapeutics Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biologic Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biologic Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biologic Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biologic Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Biologic Therapeutics Drugs include Aurobindo Pharma, Concord Biotech, H. Lundbeck, Retractable Technologies, Smith Medical, AstraZeneca, GlaxoSmithKline, Pfizer and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biologic Therapeutics Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biologic Therapeutics Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Biologic Therapeutics Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologic Therapeutics Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biologic Therapeutics Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Biologic Therapeutics Drugs sales, projected growth trends, production technology, application and end-user industry.

Biologic Therapeutics Drugs Segment by Company

Aurobindo Pharma

Concord Biotech

H. Lundbeck

Retractable Technologies

Smith Medical

AstraZeneca

GlaxoSmithKline

Pfizer

Merck

Novartis

Biologic Therapeutics Drugs Segment by Type

Yeast

Insects Cell Culture

Avian Cell Culture

Bacteria

Transgenics

Biologic Therapeutics Drugs Segment by Application

Diabetes

Anemia

Rheumatoid Arthritis

Cancer

Others

Biologic Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Biologic Therapeutics Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic Therapeutics Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologic Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Yeast Major Manufacturers Table 3. Insects Cell Culture Major Manufacturers Table 4. Avian Cell Culture Major Manufacturers Table 5. Bacteria Major Manufacturers Table 6. Transgenics Major Manufacturers Table 7. Global Biologic Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Diabetes Major Manufacturers Table 9. Anemia Major Manufacturers Table 10. Rheumatoid Arthritis Major Manufacturers Table 11. Cancer Major Manufacturers Table 12. Others Major Manufacturers Table 13. Biologic Therapeutics Drugs Industry Trends Table 14. Biologic Therapeutics Drugs Industry Drivers Table 15. Biologic Therapeutics Drugs Industry Opportunities and Challenges Table 16. Biologic Therapeutics Drugs Industry Restraints Table 17. Global Biologic Therapeutics Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Biologic Therapeutics Drugs Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Biologic Therapeutics Drugs Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2021-2026) Table 21. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2027-2032) Table 22. Global Biologic Therapeutics Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Biologic Therapeutics Drugs Sales by Region (2021-2026) & (K Units) Table 24. Global Biologic Therapeutics Drugs Sales by Region (2027-2032) & (K Units) Table 25. Global Biologic Therapeutics Drugs Sales Market Share by Region (2021-2026) Table 26. Global Biologic Therapeutics Drugs Sales Market Share by Region (2027-2032) Table 27. Global Biologic Therapeutics Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Biologic Therapeutics Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2021-2026) Table 31. Global Biologic Therapeutics Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Biologic Therapeutics Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Biologic Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Biologic Therapeutics Drugs Manufacturers, Product Type & Application Table 35. Global Biologic Therapeutics Drugs Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Biologic Therapeutics Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Biologic Therapeutics Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2021-2026) Table 42. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2027-2032) Table 43. Global Biologic Therapeutics Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 45. Global Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 46. Global Biologic Therapeutics Drugs Sales Market Share by Type (2021-2026) Table 47. Global Biologic Therapeutics Drugs Sales Market Share by Type (2027-2032) Table 48. Global Biologic Therapeutics Drugs Price by Type (2021-2026) & (US$/Unit) Table 49. Global Biologic Therapeutics Drugs Price by Type (2027-2032) & (US$/Unit) Table 50. Global Biologic Therapeutics Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2021-2026) Table 54. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2027-2032) Table 55. Global Biologic Therapeutics Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Biologic Therapeutics Drugs Sales Market Share by Application (2021-2026) Table 59. Global Biologic Therapeutics Drugs Sales Market Share by Application (2027-2032) Table 60. Global Biologic Therapeutics Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global Biologic Therapeutics Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. Aurobindo Pharma Company Information Table 63. Aurobindo Pharma Business Overview Table 64. Aurobindo Pharma Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio Table 66. Aurobindo Pharma Recent Development Table 67. Concord Biotech Company Information Table 68. Concord Biotech Business Overview Table 69. Concord Biotech Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Concord Biotech Biologic Therapeutics Drugs Product Portfolio Table 71. Concord Biotech Recent Development Table 72. H. Lundbeck Company Information Table 73. H. Lundbeck Business Overview Table 74. H. Lundbeck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. H. Lundbeck Biologic Therapeutics Drugs Product Portfolio Table 76. H. Lundbeck Recent Development Table 77. Retractable Technologies Company Information Table 78. Retractable Technologies Business Overview Table 79. Retractable Technologies Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Retractable Technologies Biologic Therapeutics Drugs Product Portfolio Table 81. Retractable Technologies Recent Development Table 82. Smith Medical Company Information Table 83. Smith Medical Business Overview Table 84. Smith Medical Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Smith Medical Biologic Therapeutics Drugs Product Portfolio Table 86. Smith Medical Recent Development Table 87. AstraZeneca Company Information Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. AstraZeneca Biologic Therapeutics Drugs Product Portfolio Table 91. AstraZeneca Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pfizer Biologic Therapeutics Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Merck Biologic Therapeutics Drugs Product Portfolio Table 106. Merck Recent Development Table 107. Novartis Company Information Table 108. Novartis Business Overview Table 109. Novartis Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Novartis Biologic Therapeutics Drugs Product Portfolio Table 111. Novartis Recent Development Table 112. North America Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 115. North America Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 116. North America Biologic Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Biologic Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 121. North America Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 122. North America Biologic Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Biologic Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Biologic Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 130. North America Biologic Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Biologic Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 133. Canada Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 134. Europe Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 137. Europe Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 138. Europe Biologic Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Biologic Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 143. Europe Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 144. Europe Biologic Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Biologic Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Biologic Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Europe Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 151. Europe Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 152. Europe Biologic Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Biologic Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 155. France Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 156. U.K. Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 157. Italy Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 159. China Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 160. China Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 161. China Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 162. China Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 163. China Biologic Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Biologic Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 166. China Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 167. China Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 168. China Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 169. China Biologic Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Biologic Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 174. Asia Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 175. Asia Biologic Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Biologic Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 180. Asia Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 181. Asia Biologic Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Biologic Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Biologic Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 188. Asia Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 189. Asia Biologic Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Biologic Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 192. South Korea Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 193. India Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 194. Australia Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Biologic Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Biologic Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Biologic Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Biologic Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Biologic Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Biologic Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Biologic Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 218. Argentina Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 219. Chile Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 220. Colombia Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 221. Peru Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 223. Israel Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 224. UAE Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 225. Turkey Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 226. Iran Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 227. Egypt Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Biologic Therapeutics Drugs Distributors List Table 231. Biologic Therapeutics Drugs Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Biologic Therapeutics Drugs Image Figure 2. Global Biologic Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Therapeutics Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Yeast Image Figure 5. Insects Cell Culture Image Figure 6. Avian Cell Culture Image Figure 7. Bacteria Image Figure 8. Transgenics Image Figure 9. Global Biologic Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Biologic Therapeutics Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Diabetes Image Figure 12. Anemia Image Figure 13. Rheumatoid Arthritis Image Figure 14. Cancer Image Figure 15. Others Image Figure 16. Global Biologic Therapeutics Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 18. Global Biologic Therapeutics Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Biologic Therapeutics Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2021-2032) Figure 21. Global Biologic Therapeutics Drugs Sales (2021-2032) & (K Units) Figure 22. Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Biologic Therapeutics Drugs Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Biologic Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Europe Biologic Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 26. China Biologic Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Biologic Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Biologic Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 29. Global Biologic Therapeutics Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Biologic Therapeutics Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Biologic Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Biologic Therapeutics Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2021-2032) Figure 35. Global Biologic Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Biologic Therapeutics Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Biologic Therapeutics Drugs Sales Market Share by Type (2021-2032) Figure 38. Global Biologic Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Biologic Therapeutics Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2021-2032) Figure 41. Global Biologic Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Biologic Therapeutics Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Biologic Therapeutics Drugs Sales Market Share by Application (2021-2032) Figure 44. North America Biologic Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 45. North America Biologic Therapeutics Drugs Sales Share by Type (2021-2032) Figure 46. North America Biologic Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 47. North America Biologic Therapeutics Drugs Sales Share by Application (2021-2032) Figure 48. North America Biologic Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 49. North America Biologic Therapeutics Drugs Sales Share by Country (2021-2032) Figure 50. Europe Biologic Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 51. Europe Biologic Therapeutics Drugs Sales Share by Type (2021-2032) Figure 52. Europe Biologic Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 53. Europe Biologic Therapeutics Drugs Sales Share by Application (2021-2032) Figure 54. Europe Biologic Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 55. Europe Biologic Therapeutics Drugs Sales Share by Country (2021-2032) Figure 56. China Biologic Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 57. China Biologic Therapeutics Drugs Sales Share by Type (2021-2032) Figure 58. China Biologic Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 59. China Biologic Therapeutics Drugs Sales Share by Application (2021-2032) Figure 60. Asia Biologic Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 61. Asia Biologic Therapeutics Drugs Sales Share by Type (2021-2032) Figure 62. Asia Biologic Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 63. Asia Biologic Therapeutics Drugs Sales Share by Application (2021-2032) Figure 64. Asia Biologic Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 65. Asia Biologic Therapeutics Drugs Sales Share by Country (2021-2032) Figure 66. SAMEA Biologic Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 67. SAMEA Biologic Therapeutics Drugs Sales Share by Type (2021-2032) Figure 68. SAMEA Biologic Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 69. SAMEA Biologic Therapeutics Drugs Sales Share by Application (2021-2032) Figure 70. SAMEA Biologic Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 71. SAMEA Biologic Therapeutics Drugs Sales Share by Country (2021-2032) Figure 72. Biologic Therapeutics Drugs Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Biologic Therapeutics Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast
  • Insects Cell Culture
  • Avian Cell Culture
  • Bacteria
  • Transgenics
Applications
  • Diabetes
  • Anemia
  • Rheumatoid Arthritis
  • Cancer
  • Others
Companies covered
  • Aurobindo Pharma
  • Concord Biotech
  • H. Lundbeck
  • Retractable Technologies
  • Smith Medical
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biologic Therapeutics Drugs Market by Type
  3. 1.2.1 Global Biologic Therapeutics Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Yeast
  5. 1.2.3 Insects Cell Culture
  6. 1.2.4 Avian Cell Culture
  7. 1.2.5 Bacteria
  8. 1.2.6 Transgenics
  9. 1.3 Biologic Therapeutics Drugs Market by Application
  10. 1.3.1 Global Biologic Therapeutics Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Diabetes
  12. 1.3.3 Anemia
  13. 1.3.4 Rheumatoid Arthritis
  14. 1.3.5 Cancer
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Biologic Therapeutics Drugs Market Dynamics
  1. 2.1 Biologic Therapeutics Drugs Industry Trends
  2. 2.2 Biologic Therapeutics Drugs Industry Drivers
  3. 2.3 Biologic Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutics Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Biologic Therapeutics Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Biologic Therapeutics Drugs Revenue by Region
  3. 3.2.1 Global Biologic Therapeutics Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biologic Therapeutics Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Biologic Therapeutics Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Biologic Therapeutics Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Biologic Therapeutics Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Biologic Therapeutics Drugs Sales by Region
  9. 3.4.1 Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Biologic Therapeutics Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Biologic Therapeutics Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Biologic Therapeutics Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Biologic Therapeutics Drugs Revenue by Manufacturers
  2. 4.1.1 Global Biologic Therapeutics Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Biologic Therapeutics Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biologic Therapeutics Drugs Sales by Manufacturers
  6. 4.2.1 Global Biologic Therapeutics Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Biologic Therapeutics Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Biologic Therapeutics Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Biologic Therapeutics Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Biologic Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Biologic Therapeutics Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Biologic Therapeutics Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Biologic Therapeutics Drugs Market CR5 and HHI
  16. 4.8.2 2025 Biologic Therapeutics Drugs Tier 1, Tier 2, and Tier 3
5 Biologic Therapeutics Drugs Market by Type
  1. 5.1 Global Biologic Therapeutics Drugs Revenue by Type
  2. 5.1.1 Global Biologic Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Biologic Therapeutics Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Biologic Therapeutics Drugs Sales by Type
  6. 5.2.1 Global Biologic Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biologic Therapeutics Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Biologic Therapeutics Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Biologic Therapeutics Drugs Price by Type
6 Biologic Therapeutics Drugs Market by Application
  1. 6.1 Global Biologic Therapeutics Drugs Revenue by Application
  2. 6.1.1 Global Biologic Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Biologic Therapeutics Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Biologic Therapeutics Drugs Sales by Application
  6. 6.2.1 Global Biologic Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Biologic Therapeutics Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Biologic Therapeutics Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Biologic Therapeutics Drugs Price by Application
7 Company Profiles
  1. 7.1 Aurobindo Pharma
  2. 7.1.1 Aurobindo Pharma Company Information
  3. 7.1.2 Aurobindo Pharma Business Overview
  4. 7.1.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
  6. 7.1.5 Aurobindo Pharma Recent Developments
  7. 7.2 Concord Biotech
  8. 7.2.1 Concord Biotech Company Information
  9. 7.2.2 Concord Biotech Business Overview
  10. 7.2.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
  12. 7.2.5 Concord Biotech Recent Developments
  13. 7.3 H. Lundbeck
  14. 7.3.1 H. Lundbeck Company Information
  15. 7.3.2 H. Lundbeck Business Overview
  16. 7.3.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
  18. 7.3.5 H. Lundbeck Recent Developments
  19. 7.4 Retractable Technologies
  20. 7.4.1 Retractable Technologies Company Information
  21. 7.4.2 Retractable Technologies Business Overview
  22. 7.4.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
  24. 7.4.5 Retractable Technologies Recent Developments
  25. 7.5 Smith Medical
  26. 7.5.1 Smith Medical Company Information
  27. 7.5.2 Smith Medical Business Overview
  28. 7.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
  30. 7.5.5 Smith Medical Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck Biologic Therapeutics Drugs Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Biologic Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Biologic Therapeutics Drugs Product Portfolio
  60. 7.10.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Biologic Therapeutics Drugs Market Size by Type
  2. 8.1.1 North America Biologic Therapeutics Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Biologic Therapeutics Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Biologic Therapeutics Drugs Price by Type (2021-2032)
  5. 8.2 North America Biologic Therapeutics Drugs Market Size by Application
  6. 8.2.1 North America Biologic Therapeutics Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Biologic Therapeutics Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Biologic Therapeutics Drugs Price by Application (2021-2032)
  9. 8.3 North America Biologic Therapeutics Drugs Market Size by Country
  10. 8.3.1 North America Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Biologic Therapeutics Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Biologic Therapeutics Drugs Market Size by Type
  2. 9.1.1 Europe Biologic Therapeutics Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Biologic Therapeutics Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Biologic Therapeutics Drugs Price by Type (2021-2032)
  5. 9.2 Europe Biologic Therapeutics Drugs Market Size by Application
  6. 9.2.1 Europe Biologic Therapeutics Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Biologic Therapeutics Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Biologic Therapeutics Drugs Price by Application (2021-2032)
  9. 9.3 Europe Biologic Therapeutics Drugs Market Size by Country
  10. 9.3.1 Europe Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Biologic Therapeutics Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Biologic Therapeutics Drugs Market Size by Type
  2. 10.1.1 China Biologic Therapeutics Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Biologic Therapeutics Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Biologic Therapeutics Drugs Price by Type (2021-2032)
  5. 10.2 China Biologic Therapeutics Drugs Market Size by Application
  6. 10.2.1 China Biologic Therapeutics Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Biologic Therapeutics Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Biologic Therapeutics Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biologic Therapeutics Drugs Market Size by Type
  2. 11.1.1 Asia Biologic Therapeutics Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Biologic Therapeutics Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Biologic Therapeutics Drugs Price by Type (2021-2032)
  5. 11.2 Asia Biologic Therapeutics Drugs Market Size by Application
  6. 11.2.1 Asia Biologic Therapeutics Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Biologic Therapeutics Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Biologic Therapeutics Drugs Price by Application (2021-2032)
  9. 11.3 Asia Biologic Therapeutics Drugs Market Size by Country
  10. 11.3.1 Asia Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Biologic Therapeutics Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biologic Therapeutics Drugs Market Size by Type
  2. 12.1.1 SAMEA Biologic Therapeutics Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Biologic Therapeutics Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Biologic Therapeutics Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Biologic Therapeutics Drugs Market Size by Application
  6. 12.2.1 SAMEA Biologic Therapeutics Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Biologic Therapeutics Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Biologic Therapeutics Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Biologic Therapeutics Drugs Market Size by Country
  10. 12.3.1 SAMEA Biologic Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Biologic Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Biologic Therapeutics Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Biologic Therapeutics Drugs Value Chain Analysis
  2. 13.1.1 Biologic Therapeutics Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Biologic Therapeutics Drugs Production Mode & Process
  6. 13.2 Biologic Therapeutics Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Biologic Therapeutics Drugs Distributors
  9. 13.2.3 Biologic Therapeutics Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst